CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
TRANSFORMER aims to develop a novel treatment for osteosarcoma that combines bone regeneration materials with cold atmospheric plasma-treated hydrogels. This innovative approach seeks to treat bone cancer without the side effects associated with traditional chemotherapy while promoting bone healing.
Improving the survival of patients with osteosarcoma has long proved challenging.
Osteosarcoma is a rare bone cancer (less than 0.2% of all cancers).
However, it affects mainly children and young adolescents.
The standard therapy for osteosarcoma consists in the surgeon removing the entire tumor with negative margins (resection of larger areas of bone than the tumor itself), to ensure that no cancer cells are found at the edge of the tissue removed.
This means that in some cases these surgeries…
UNIVERSITAT POLITECNICA DE CATALUNYA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
